---
figid: PMC4221550__nihms615007f3
figtitle: smicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4221550
filename: nihms615007f3.jpg
figlink: /pmc/articles/PMC4221550/figure/F3/
number: F3
caption: Predicted miR-340 targets are oval and outlined in a solid line and targets
  found to be predicted and regulated by miR-340 are oval and outlined in a dashed
  line. MAPK components not predicted to be targeted by miR-340 are depicted as a
  solid outlined hexagon. miR-340 target predictions are based on prediction overlap
  between at least 4 of 6 miRNA target prediction databases including DIANAmT, miRanda,
  miRDB, miRWalk, RNA22, and TargetScan.
papertitle: smicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma.
reftext: Ashley M. Poenitzsch, et al. Arch Biochem Biophys. ;563:118-124.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9178823
figid_alias: PMC4221550__F3
figtype: Figure
redirect_from: /figures/PMC4221550__F3
ndex: 4777fa08-df0f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4221550__nihms615007f3.html
  '@type': Dataset
  description: Predicted miR-340 targets are oval and outlined in a solid line and
    targets found to be predicted and regulated by miR-340 are oval and outlined in
    a dashed line. MAPK components not predicted to be targeted by miR-340 are depicted
    as a solid outlined hexagon. miR-340 target predictions are based on prediction
    overlap between at least 4 of 6 miRNA target prediction databases including DIANAmT,
    miRanda, miRDB, miRWalk, RNA22, and TargetScan.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CACNA1A
  - CACNA1B
  - CACNA1C
  - CACNA1D
  - CACNA1E
  - CACNA1F
  - CACNA1G
  - CACNA1H
  - CACNA1I
  - CACNA1S
  - CACNA2D1
  - CACNA2D2
  - CACNA2D3
  - CACNA2D4
  - CACNB1
  - CACNB2
  - CACNB3
  - CACNB4
  - CACNG1
  - CACNG2
  - CACNG3
  - CACNG4
  - CACNG5
  - CACNG6
  - CACNG7
  - CACNG8
  - NGF
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - SLC25A3
  - REG1A
  - PTPRU
  - THRA
  - MPI
  - SLPI
  - RASGRP1
  - RASGRP2
  - RASGRP3
  - RASGRP4
  - EGF
  - EGFR
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - SRF
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGR
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K2
  - PPP6R3
  - MOS
  - MOCOS
  - NFIC
  - MYC
  - GNA12
  - GNA13
  - RPS6KA3
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - MAPT
  - Cancer
  - Noonan syndrome
---
